Back

Side effects and tolerance of SGLT2 inhibitors and ARNIs in patients with heart failure: what to look out for and manage.

28 August 2022 (08:52 - 09:14)
Organised by:
Congress Presentation Part of: 2021 ESC HF Guidelines: implementation in daily practice Chronic Heart Failure ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Marc Ferrini

Lyon (France)

3 More presentations in this session

Presentation thumbnail
ESC HF Guidelines 2021: which recommendations for the management of chronic heart failure are most important for the general cardiologist?
Doctor R. Christodorescu (Timisoara, RO)
Slides Video
Presentation thumbnail
How to manage acute heart failure in 2022.
Professor A. Mebazaa (Paris, FR)
Slides Video
Presentation thumbnail
2021 ESC HF Guidelines: implementation in daily practice – the final word.
Video

Access the full session

Session thumbnail
2021 ESC HF Guidelines: implementation in daily practice
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 08:52 CET
You may be interested in
thumbnail
Congress Presentation
A broader benefit: from heart failure to wider cardio-renal-metabolic (CRM) conditions
31 August 2024
thumbnail
Congress Presentation
The impact of ARNI and SGLT2i on cardiac and kidney endpoints
21 May 2023
thumbnail
Congress Session
How to optimise RAASi therapy
23 May 2022
thumbnail
Congress Session
Guidelines in Practice: cardio-renal protection in patients with diabetes
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources